Research material is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-11-07. Numbers and descriptions here follow the published literature rather than marketing material.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also dissolves in common polar solvents |
| Storage temperature | Minus 20 degrees Celsius or lower | Applies to dry powder, desiccated and dark |
| Typical analytical methods | Reversed-phase HPLC and mass spectrometry | Used together for purity and identity |
| Primary degradation route | Hydrolysis and aggregation | No cysteine present, so disulfide formation is unlikely |
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
=== Fish === After the fishes were treated with BLCO for 30days, the blood glucose outstandingly elevated, dose dependent of crude oil. Similarly, the degree of total protein concentration and albumin levels increased in proportion to the amount of BLCO. aspartate transaminase (AST) and alanine transaminase (ALT) concentrations rose too. Fishes which are exposed to crude oil get to have PAHs in their tissue and according to Wegwu and Omeodu, they “are activated to highly reactive epoxides by cytochrome P450-containing enzyme systems”. DNA bases automatically respond with these epoxides and point mutations are occurred as a result of it. With regard to glucose levels, if they are extremely high, it means severe oxidation stress in fish. In addition to it, excessive total protein levels of fish specify water imbalance and damage of haemo-concentration. These are resulted by harmful components of crude oil and it would induce damage in cellular membrane, less fluidity in membrane and elimination of cell as well.
TabA (P31851), an enzyme related to lysA (diaminopimelate decarboxylase) TabB (P31852), an enzyme related to dapD (THDPA succinyl-CoA succinyltransferase, THDPA-ST) TblA (P31850), an enzyme with no close paralogs (identified as a member of SAMe-dependent methyltransferase superfamily by InterPro) This pathway produces TBL; the enzyme TblF finalize the synthesis by linking TBL to Thr to form tabtoxin.
== Further reading == Brooks, Maurice (1965). The Appalachians: The Naturalist's America; illustrated by Lois Darling and Lo Brooks. Boston; Houghton Mifflin Company. Caudill, Harry M. (1963). Night Comes to the Cumberlands. ISBN 0-316-13212-8. Constantz, George (2004). Hollows, Peepers, and Highlanders: an Appalachian Mountain Ecology (2nd edition). West Virginia University Press; Morgantown. 359 p. Olson, Ted (1998). Blue Ridge Folklife. University Press of Mississippi, 211 pages, ISBN 1-57806-023-0. Rehder, John (2013). "Appalachian Folkways", Koxville: University of Tennessee Press. Semple, E. C. (1903). Chapters III, IV, and V. American History and Its Geographic Conditions. Boston. Weidensaul, Scott (2000). Mountains of the Heart: A Natural History of the Appalachians. Fulcrum Publishing, 288 pages, ISBN 1-55591-139-0. Bailey Willis, The Northern Appalachians, and C. W. Hayes, The Southern Appalachians, both in The Physiography of the United States. Appalachian flora and fauna-related journals Banisteria, a journal devoted to the natural history of Virginia. Castanea, the journal of the Southern Appalachian Botanical Society. The Journal of the Torrey Botanical Society.
=== Botanical extracts === When utilized in tincture method extractions, specifically as a 10% solution, glycerol prevents tannins from precipitating in ethanol extracts of plants (tinctures). It is also used as an "alcohol-free" alternative to ethanol as a solvent in preparing herbal extractions. It is less extractive when utilized in a standard tincture methodology. Alcohol-based tinctures can also have the alcohol removed and replaced with glycerol for its preserving properties. Such products are not "alcohol-free" in a scientific or FDA regulatory sense, as glycerol contains three hydroxyl groups. Fluid extract manufacturers often extract herbs in hot water before adding glycerol to make glycerites. When used as a primary "true" alcohol-free botanical extraction solvent in non-tincture based methodologies, glycerol has been shown to possess a high degree of extractive versatility for botanicals including removal of numerous constituents and complex compounds, with an extractive power that can rival that of alcohol and water–alcohol solutions. That glycerol possesses such high extractive power assumes it is utilized with dynamic (critical) methodologies as opposed to standard passive "tincturing" methodologies that are better suited to alcohol. Glycerol does not denature or render a botanical's constituents inert as alcohols (ethanol, methanol, and so on) do.
Both enantiomers of alazocine have very low affinity for the sigma σ2 receptor (Ki = 13,694 nM and 4,581 nM for the (+)- and (−)-enantiomers, respectively, in rat brain membranes or rat PC12 cells). As such, due to its high affinity for the σ1 receptor, (+)-alazocine can be used to distinguish between the two sigma receptor subtypes in scientific research, for instance in radioligand binding assays. Taken together, (−)-alazocine is a selective partial agonist of the κ-opioid receptor, antagonist of the μ-opioid receptor, and to a far lesser extent agonist of the δ-opioid receptor with very low affinity for the sigma receptors, while (+)-alazocine is a selective agonist of the sigma σ1 receptor and to a lesser (~10-fold) extent antagonist of the NMDA receptor with low affinity for the opioid and sigma σ2 receptors.
Sources: en.wikipedia.org
== Deliverables == The EFI's primary deliverable is development and dissemination of an integrated sequence/structure strategy for functional assignment. The EFI now offers access to two high-throughput docking tools, a web tool for comparing protein sequences within entire protein families, and a web tool for composing a genome context inventory based on a protein sequence similarity network. Additionally, as the strategy is developed, data and clones generated by the EFI are made freely available via several online resources.
In a study on dinosterol side chain synthesis in the marine heterotrophic dinoflagellate, Crypthecodinium cohnii, the dinoflagellates were cultured with methionine-[CD3]. GC-MS analysis revealed that the C-23 methyl group contained three deuterium atoms that were introduced by transmethylation from methionine. The C-24 methyl group contained only two deuterium atoms, consistent with a 24-methylenesterol intermediate, which is reduced to the resulting 24-methyl side chain. This mechanism has been previously reported in fungi, a chrysophyte alga and a diatom. Importantly, no deuterium was incorporated into cholesterol or cholesta-5,7-dien-3β-ol, which are the major 4-methyl-sterols in Crypthecodinium cohnii. A suggested biosynthetic mechanism for side chain alkylations at C-23 and C-24 in dinosterol has been proposed.
Department of Defense on human–animal bonding determined that there was an improvement and enrichment of life when animals were closely involved with humans. The study tested blood levels and noticed a rise in oxytocin in humans and animals which participated; oxytocin has the ability to lower stress, heart rate, and fear levels in humans and animals. Historically, animals were domesticated for functional use; for example, dogs for herding and tracking, and cats for killing mice or rats. Today, in Western societies, their function is primarily bonding. For example, current studies show that 60–80% of dogs sleep with their owners at night in the bedroom, either in or on the bed. Moreover, in the past the majority of cats were kept outside (barn cats) whereas today most cats are kept indoors (housecats) and considered part of the family. Currently, in the US, for example, 1.2 billion animals are kept as pets, primarily for bonding purposes. In addition, as of 1995, there were over 30 research institutions looking into the potential benefits of the human–animal bond.
There are several strategies for removal and/or negation of ion suppression. These approaches may require in-depth understanding of the ionisation mechanisms involved in different ionisation sources or may be completely independent of the physical factors involved.
Sources: en.wikipedia.org
Reversed-phase liquid chromatography with ultraviolet detection gives a purity estimate, while mass spectrometry confirms molecular mass and flags modifications. Amino acid analysis can add compositional confirmation. Results are most meaningful when a validated reference standard is run alongside the sample.
Cold, dry, and dark conditions are standard, typically at or below minus twenty degrees Celsius for long-term holding. Vials are usually warmed to room temperature before opening to prevent condensation. Repeated warming and cooling of the same vial is generally avoided.
This depends on pH, buffer, and concentration, with acidic conditions often reported as more favorable. Hydrolysis accelerates at room temperature, so solutions are commonly prepared fresh or stored frozen in single-use aliquots. No single shelf life applies across formulations.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.